Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics

NCT00739752 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1747

Last updated 2018-11-09

Study results available
· View outcomes & findings →

Summary

The goal of this study is to evaluate two sets of interventions to increase acceptance of hepatitis B virus (HBV) vaccination in patients attending sexually transmitted disease (STD) clinics. The 1st set of interventions, with 3 levels, is based on message framing. The 3 levels are: 1. information only; 2. gain-framed message; and 3. loss-framed message. The 2nd set of interventions, with 2 levels, involves how the vaccine is recommended by the health care provider. The 2 levels are: 1. HBV vaccine offered; and 2. HBV vaccine recommended. The outcome of interest is1st dose acceptance.

Conditions

  • Hepatitis B Virus

Interventions

BEHAVIORAL

Non-Framed-Offered

Subjects received information only and are offered the vaccine.

BEHAVIORAL

Non-Framed-Recommended

Subjects receive information only and are recommended the vaccine.

BEHAVIORAL

Gain-Framed-Offered

Subjects receive gain-framed messages and are offered the vaccine.

BEHAVIORAL

Gain-Framed-Recommended

Subjects receive gain-framed messages and are recommended the vaccine.

BEHAVIORAL

Loss-Framed-Offered

Subjects receive loss-framed messages and are offered the vaccine.

BEHAVIORAL

Loss-Framed-Recommended

Subjects receive loss-framed messages and are recommended the vaccine.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH
  • Indiana University

    lead OTHER

Principal Investigators

  • Gregory D Zimet, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2007-06-30
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00739752 on ClinicalTrials.gov